Effectiveness of highly active antiretroviral therapy in HIV-positive children: Evaluation at 12 months in a routine program in Cambodia

Pediatrics

Volumn 120, Issue 5, 2007, Pages

  Janssens, Bart ^a,f   Raleigh, Brian ^a   Soeung, Seithaboth ^b   Akaob, Kazumi ^b   Te, Vantha ^c   Gupta, Jitendra ^a   Vun, Mean Chhy ^d   Ford, Nathan ^a   Nouhinf, Janin ^e   Nerrienet, Eric ^e  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b Angkor Hospital for Children   (Cambodia)

^c Department of Pediatrics   (Cambodia)

^d Ministry of Health Cambodia   (Cambodia)

^e INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^f Phnom Penh ^*  (Switzerland)

Author keywords

Cambodia; Children; Genotyping; HAART; HIV; Viral load

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; TRIVIRO; UNCLASSIFIED DRUG; ZIDOVUDINE;

ARTICLE; BODY WEIGHT; CAMBODIA; CD4+ T LYMPHOCYTE; CHILD; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SURVIVAL; TREATMENT DURATION; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAMBODIA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; VIRAL LOAD;

EID: 36048946593     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-3503     Document Type: Article

References (20)

1. United Nations Children's Fund; Joint United Nations Programme on HIV/AIDS. A call to action: children, the missing face of AIDS. Available at: www.unicef.org/publications/files/AIDS_Launch_final_14Oct.pdf. Accessed September 10, 2007
2. Joint United Nations Programme on HIV/AIDS. AIDS epidemic update: December 2006. Available at: www.unaids.org/EpiReport/2006/2006_EpiUpdate_en. pdf. Accessed September 10, 2007
3. Viani RM, Araneta MR, Deville JG, Spector SA. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2004;39:725-731
4. Gibb DM, Duong T, Tookey PA, et al. National Study of HIV in Pregnancy and Childhood Collaborative HIV Paediatric Study. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ. 2003;327:1019
5. Sanchez JM, Ramos Amador JT, Fernandez de Miguel S, et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children [published correction appears in BMJ. 2004;328:686]. Pediatr Infect Dis J. 2003;22:863-867
6. de Martino M, Tovo PA, Balducci M, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA. 2000;284:190-197
7. Ghaffari G, Passalacqua DJ, Caicedo JL, Goodenow MM, Sleasman JW. Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy. Pediatrics. 2004; 114(5). Available at: www.pediatrics.org/cgi/content/full/114/5/e604
8. Puthanakit T, Oberdorfer A, Akarathum N, et al. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clin Infect Dis. 2005;41:100-107
9. Matida LH, Marcopito LF, Succi RC, et al. Improving survival among Brazilian children with perinatally-acquired AIDS. Braz J Infect Dis. 2004;8:419-423
10. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS. 2004;18:1905-1913
11. Kline MW, Matusa RF, Copaciu L, Calles NR, Kline NE, Schwarzwald HL. Comprehensive pediatric human immunodeficiency virus care and treatment in Constanta, Romania: implementation of a program of highly active antiretroviral therapy in a resource-poor setting. Pediatr Infect Dis J. 2004;23:695-700
12. United Nations Development Programme. Human development indicators. Available at: http://hdr.undp.org/reports/global/2005/pdf/HDR05HDI.pdf. Accessed September 10, 2007
13. World Health Organization. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access - recommendations for a public health approach. Available at: www.who.int/hiv/pub/ guidelines/art/en/index.html. Accessed September 10, 2007
14. World Health Organization. Prequalification programme: priority essential medicines - a United Nations programme managed by WHO. Available at: http://mednet3.who.int/prequal. Accessed September 10, 2007
15. Ponnet M, Frederix K, Petdachai W, Wilson D, Eksaengsri A, Zachariah R. A drug dosage table is a useful tool to facilitate prescriptions of antiretroviral drugs for children in Thailand. Int J STD AIDS. 2005;16:420-426
16. National Institutes of Health. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Available at: http://aidsinfo.nih.gov/ ContentFiles/PediatricGuidelines.pdf. Accessed September 10, 2007
17. van Rossum AM, Fraaij PL, de Groot R. Efficacy of highly active antiretroviral therapy in HIV-1 infected children. Lancet Infect Dis. 2002;2:93-102
18. Calmy A, Pinoges L, Szumilin E, Zachariah R, Ford N, Ferradini L; Médecins Sans Frontières. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS. 2006;20:1163-1169
19. Chokephaibulkit K, Plipat N, Cressey TR, et al. Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine. AIDS. 2005;19:1495-1499
20. Sharland M, Blanche S, Castelli G, Ramos J, Gibb DM; PENTA Steering Committee. PENTA guidelines for the use of antiretroviral therapy, 2004. Available at: www.ctu.mrc.ac.uk/penta/guidelin.pdf. Accessed September 10, 2007